Aspira Women's Health Files S-1/A Amendment

TL;DR

Aspira Women's Health filed an S-1/A on 10/20/25. Looks like they're raising capital or making a regulatory move.

AI Summary

Aspira Women's Health Inc. filed an amendment (S-1/A) on October 20, 2025, for its registration statement. The company, formerly known as Vermillion, Inc. and Ciphergen Biosystems Inc., is incorporated in Delaware and headquartered in Austin, Texas. This filing relates to the Securities Act of 1933.

Why It Matters

This S-1/A filing indicates Aspira Women's Health is actively pursuing a securities offering or other regulatory actions, which could impact its financial structure and future operations.

Risk Assessment

Risk Level: medium — S-1/A filings often precede significant corporate actions like stock offerings, which carry inherent market and financial risks.

Key Numbers

• 333-290633 — SEC File Number (Identifies this specific registration statement)
• 2835 — SIC Code (Industry classification for diagnostic substances)

Key Players & Entities

• Aspira Women's Health Inc. (company) — Registrant
• October 20, 2025 (date) — Filing Date
• 333-290633 (other) — SEC File Number
• Vermillion, Inc. (company) — Former Company Name
• Ciphergen Biosystems Inc (company) — Former Company Name
• Michael Buhle (person) — Chief Executive Officer

FAQ

From the Filing

0001493152-25-018669.txt : 20251020 0001493152-25-018669.hdr.sgml : 20251020 20251020170653 ACCESSION NUMBER: 0001493152-25-018669 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 16 FILED AS OF DATE: 20251020 DATE AS OF CHANGE: 20251020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aspira Women's Health Inc. CENTRAL INDEX KEY: 0000926617 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences EIN: 330595156 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-290633 FILM NUMBER: 251404570 BUSINESS ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 BUSINESS PHONE: 512-519-0400 MAIL ADDRESS: STREET 1: 12117 BEE CAVES ROAD BUILDING THREE STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78738 FORMER COMPANY: FORMER CONFORMED NAME: VERMILLION, INC. DATE OF NAME CHANGE: 20070824 FORMER COMPANY: FORMER CONFORMED NAME: CIPHERGEN BIOSYSTEMS INC DATE OF NAME CHANGE: 20000316 FORMER COMPANY: FORMER CONFORMED NAME: ABIOTIC SYSTEMS DATE OF NAME CHANGE: 19950407 S-1/A 1 forms-1a.htm S-1/A As filed with the Securities and Exchange Commission on October 20, 2025 Registration Statement No. 333-290633 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ASPIRA WOMEN’S HEALTH INC. (Exact name of registrant as specified in its charter) Delaware 2835 33-0595156 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas 78738 (512) 519-0400 (Address, including zip code and telephone number, including area code of registrant’s principal executive offices) Michael Buhle Chief Executive Officer and Chief Commercial Officer Aspira Women’s Health Inc. 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas 78738 (512) 519-0400 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: J. Eric Johnson Winston & Strawn LLP 800 Capitol Street, Suite 2400 Houston, TX 77002 Tel.: (713) 651-2647 Approximate date of commencement of proposed sale to the public: As soon as practicable after the date this registration statement becomes effective. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box: ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Eme